logologo
QuantliQuantli

Veracyte Inc

VCYT

NASDAQ

Biotechnology

$41.25

USD

-1.35 (-3.17%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $3.35B

Volume 1.7M

Price Target

$44.00$69.00

USD

The 4 analysts offering 1-year price forecasts have a max estimate of $69.00 and a min estimate of $44.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$59.50

+$14.7 vs prior

Implied Upside

+44.2%

+35.6% vs prior

Analyst Covering

4

-2 vs prior period

Consensus

Hold

Declined vs prior

Signal Quality

Consensus Freshness

40%

A mix of recent and older ratings shape this consensus

Analyst Agreement

Low

Targets are widely dispersed - limited agreement on price

Mean vs Median

$3.00 Gap

Median $62.50 vs avg $59.50 - a few cautious outliers are pulling the average down

Analyst Consensus

Strong Sell

Hold

Strong Buy

Hold

2 Buy

1 Hold

1 Sell

Rating Breakdown

Strong Buy

0

Buy

2

Hold

1

Sell

1

Strong Sell

0

4 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Tejas Savant

Morgan Stanley

Sell

Maintained

1 week ago

Plus
Plus
Plus

Mike Matson

Needham

Buy

Maintained

2 weeks ago

Plus
Plus
Plus

Kyle Mikson

Canaccord Genuity

Hold

Maintained

4 weeks ago

Plus
Plus
Plus

Subbu Nambi

Guggenheim

Buy

Maintained

1 month ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

IOVA

Iovance Biotherapeutics Inc

$6.98

+7.1%

ARQT

Arcutis Biotherapeutics Inc

$26.19

+1.4%

CLDX

Celldex Therapeutics Inc

$41.95

-1.6%

DNLI

Denali Therapeutics Inc

$24.40

-1.7%

LEGN

Legend Biotech Corp

$20.37

+0.5%

IMNM

Immunome Inc

$27.20

+3.0%

VKTX

Viking Therapeutics Inc

$33.19

+0.8%

IDYA

IDEAYA Biosciences Inc

$36.30

-1.0%